Positions 26–50 of 130.
unpopular opinion: most of what gets said here about triple agonist is guesswork, which sounds obvious until you try to state the evidence for it. Kept a log…
can we stop arguing about retatrutide until somebody posts a number, and I want the answer with the reasoning attached rather than just the conclusion. Where the…
TRIUMPH is the most under-discussed thing on this board. Making the case below, and I expect to lose some of it in the comments. Stopped at a low step because there was…
The one-line version is the title: phase 2 is not what most of this community thinks it is. The rest is why. It is a triple agonist at the GLP-1, GIP and glucagon…
Vendor-level purity averages over time, built from independent results rather than vendor claims. Transparent methodology, open dataset.
Browse resultsCheck-in as promised in the title: anyone else notice glucagon kicking in around week 51. Nothing containing this compound is approved anywhere. Research-use-only…
is it normal to get injection-site soreness at week 72. Full detail below, and I have tried to keep the editorialising out of it. The phase 2 readout ran to 48 weeks in…
does phase 2 actually matter or is it forum lore at this point, and I want the answer with the reasoning attached rather than just the conclusion. Where the evidence…
Something I keep coming back to: dose escalation is the most under-discussed thing on this board. The early fullness profile felt different rather than worse. Hard to…
Thinking out loud about this: the glucagon thing finally clicked for me and I want to write it down. Read the phase 2 paper twice before ordering anything. Recommend…
triple agonist: what the trials say vs what this community says. Making the case below, and I expect to lose some of it in the comments. The phase 2 readout ran to 48…
how much of what we believe about dose escalation actually comes from glucagon threads, and I want the answer with the reasoning attached rather than just the…
week 62 check-in — 12kg down, fatigue manageable, one thing confusing me. Same spreadsheet I have been keeping since the start, nothing retrofitted. Pulling the figures…
someone explain retatrutide to me like I have not read a paper in years. I would rather ask a basic question now than get this wrong quietly for two months. Glucagon…
proposal — a flair for phase 2 posts. Disagreement welcome, but bring a concrete alternative wording. Increases in heart rate have been reported across this receptor…
reading TRIUMPH threads from 2024 and half of it aged badly, which sounds obvious until you try to state the evidence for it. It is a triple agonist at the GLP-1, GIP…
Reference standards, analytical reagents and system-suitability material. If you are running your own method, start with a known.
Reference standardsgenuine question about retatrutide that I am slightly embarrassed to ask. Searched first, found three threads that contradict each other, hence the post. The thing that…
The title is the whole question — why does nobody talk about dose escalation — but here is why I am asking. Kept a log specifically because there is so little…
help me understand retatrutide, I have read the wiki twice. I am not trying to be the "source?" guy. I would just like a source. Where the evidence actually stands,…
49 weeks, 7kg, and dose escalation was the hard part. Numbers below. Ask me the boring questions, they are the useful ones. Numbers, in the order they matter: 49 weeks…
is 97.9% actually fine or am I being sold a rounding error. I will put the method line and the batch identifier up front because that is what makes this checkable.…
phase 2 — 18 things I got wrong before I got it right. Making the case below, and I expect to lose some of it in the comments. The phase 2 readout ran to 48 weeks in a…
Six-word version is the title — 88 weeks on 2.4mg, full numbers, ask me anything boring — and the rest is context. Hard numbers: 88 weeks and 2.4mg. Anything softer…
Asking properly rather than in a comment on somebody else’s thread: help me understand triple agonist, I have read the wiki twice. Phase 2 estimates effect and finds a…
Short version of the title, which is already short: WXT reta — PeptideMeter came back 97.1% against a claimed 97.0%. Longer version underneath. Figures up front so…
am I the only one who found retatrutide harder than the injections, and I want the answer with the reasoning attached rather than just the conclusion. Where the…
Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.
Certified reference materials for peptide identity and purity work.
sigmaaldrich.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference